Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity

Journal of Clinical Investigation

Volumn 122, Issue 9, 2012, Pages 3227-3238

  Chan, Jo Anne ^a,b,c   Howell, Katherine B ^b   Reiling, Linda ^a,b   Ataide, Ricardo ^c   Mackintosh, Claire L ^d   Fowkes, Freya J I ^a,b,c   Petter, Michaela ^c   Chesson, Joanne M ^b   Langer, Christine ^a   Warimwe, George M ^d   Duffy, Michael F ^c   Rogerson, Stephen J ^c   Bull, Peter C ^d   Cowman, Alan F ^b,c   Marsh, Kevin ^d   Beeson, James G ^a,b  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ERYTHROCYTE MEMBRANE PROTEIN 1; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VARIANT SURFACE ANTIGEN ANTIBODY;

ADULT; ARTICLE; CHILD; ERYTHROCYTE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNITY; IN VITRO STUDY; MALARIA FALCIPARUM; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; DISEASE RESISTANCE; DISEASE-FREE SURVIVAL; ENDEMIC DISEASES; ERYTHROCYTES; GENETIC ENGINEERING; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; KENYA; MALARIA, FALCIPARUM; MIDDLE AGED; ORGANISMS, GENETICALLY MODIFIED; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PROMOTER REGIONS, GENETIC; PROTOZOAN PROTEINS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84865963674     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62182     Document Type: Article

References (66)

1. World Health Organization. Global Malaria Programme. World Malaria Report 2010. Geneva, Switzerland: World Health Organization; 2010.
2. Elliott SR, Beeson JG. Estimating the burden of global mortality in children aged <5 years by pathogen-specific causes. Clin Infect Dis. 2008;46(11):1794-1795. (Pubitemid 351706785)
3. Dondorp AM, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361(5):455-467.
4. Trape JF, et al. Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis. 2011;11(12):925-932.
5. Bull PC, et al. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med. 1998;4(3):358-360. (Pubitemid 28144099)
6. Beeson JG, Osier FHA, Engwerda CR. Recent insights into humoral and cellular immune responses against malaria. Trends Parasitol. 2008;24(12):578-584.
7. Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22(1):13-36.
8. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol. 2006; 28(1-2):51-60.
9. Richards JS, Beeson JG. The future for bloodstage vaccines against malaria. Immunol Cell Biol. 2009;87(5):377-390.
10. Cohen S, McGregor IA, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature. 1961;192:733-737.
11. Leech JH, Barnwell JW, Miller LH, Howard RJ. Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes. J Exp Med. 1984;159(6):1567-1575. (Pubitemid 14117068)
12. Marsh K, Howard RJ. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science. 1986;231(4734):150- 153. (Pubitemid 16154704)
13. Biggs BA, et al. Antigenic variation in Plasmodium falciparum. Proc Natl Acad Sci U S A. 1991;88(20):9171-9174.
14. Giha HA, et al. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol Lett. 2000;71(2):117-126. (Pubitemid 30089775)
15. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg. 1989;83(3):293-303. (Pubitemid 19163208)
16. Mackintosh CL, et al. Failure to respond to the surface of Plasmodium falciparum infected erythrocytes predicts susceptibility to clinical malaria amongst African children. Int J Parasitol. 2008;38(12):1445-1454.
17. Udeinya IJ, Miller LH, McGregor IA, Jensen JB. Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells. Nature. 1983;303(5916):429-431. (Pubitemid 13094881)
18. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature. 1998;395(6705):851-852.
19. Celada A, Cruchaud A, Perrin LH. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin Exp Immunol. 1982;47(3):635-644. (Pubitemid 12171956)
20. Cheng Q, et al. stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens. Mol Biochem Parasitol. 1998;97(1-2):161-176. (Pubitemid 28558710)
21. Kyes SA, Rowe JA, Kriek N, Newbold CI. Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proc Natl Acad Sci U S A. 1999;96(16):9333-9338. (Pubitemid 29374755)
22. Fernandez V, Hommel M, Chen Q, Hagblom P, Wahlgren M. Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J Exp Med. 1999;190(10):1393-1404.
23. Kaviratne M, Khan SM, Jarra W, Preiser PR. Small variant STEVOR antigen is uniquely located within Maurer's clefts in Plasmodium falciparum-infected red blood cells. Eukaryotic Cell. 2002;1(6):926-935. (Pubitemid 36557713)
24. Winter G, et al. SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes. J Exp Med. 2005;201(11):1853- 1863. (Pubitemid 41002903)
25. Beeson JG, Brown GV. Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell Mol Life Sci. 2002;59(2):258-271. (Pubitemid 34169513)
26. Winograd E, Eda S, Sherman IW. Chemical modifications of band 3 protein affect the adhesion of Plasmodium falciparum-infected erythrocytes to CD36. Mol Biochem Parasitol. 2004;136(2):243-248. (Pubitemid 38757992)
27. Sherman IW, Crandall IE, Guthrie N, Land KM. The sticky secrets of sequestration. Parasitol Today. 1995;11(10):378-384.
28. Piper KP, Roberts DJ, Day KP. Plasmodium falciparum: analysis of the antibody specificity to the surface of the trophozoite-infected erythrocyte. Exp Parasitol. 1999;91(2):161-169. (Pubitemid 29370093)
29. Baruch DI, et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell. 1995;82(1):77-87.
30. Smith JD, et al. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell. 1995;82(1):101-110.
31. Su XZ, et al. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell. 1995;82(1):89-100.
32. Roberts DJ, et al. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature. 1992;357(6380):689-692.
33. Chen Q, et al. Developmental selection of var gene expression in Plasmodium falciparum. Nature. 1998;394(6691):392-395. (Pubitemid 28373838)
34. Scherf A, et al. Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum. EMBO J. 1998;17(18):5418-5426. (Pubitemid 28427055)
35. Niang M, Yam XY, Preiser PR. The Plasmodium falciparum STEVOR multigene family mediates antigenic variation of the infected erythrocyte. PLoS Pathog. 2009;5(2):e1000307.
36. Abdel-Latif MS, et al. Antibodies to rifin: a component of naturally acquired responses to Plasmodium falciparum variant surface antigens on infected erythrocytes. Am J Trop Med Hyg. 2004;71(2):179-186. (Pubitemid 39108827)
37. Abdel-Latif MS, Khattab A, Lindenthal C, Kremsner PG, Klinkert M-Q. Recognition of variant Rifin antigens by human antibodies induced during natural Plasmodium falciparum infections. Infect Immun. 2002;70(12):7013-7021. (Pubitemid 35387937)
38. Blythe JE, et al. Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoites. Infect Immun. 2008;76(7):3329-3336.
39. Dzikowski R, Frank M, Deitsch K. Mutually exclusive expression of virulence genes by malaria parasites is regulated independently of antigen production. PLoS Pathog. 2006;2(3):e22.
40. Voss TS, et al. A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria. Nature. 2006;439(7079):1004- 1008. (Pubitemid 43292421)
41. Schreiber N, et al. Expression of Plasmodium falciparum 3D7 STEVOR proteins for evaluation of antibody responses following malaria infections in naive infants. Parasitology. 2008;135(2):155-167. (Pubitemid 351156583)
42. Beeson JG, et al. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis. 1999;180(2):464-472. (Pubitemid 30256329)
43. Mwangi TW, Ross A, Snow RW, Marsh K. Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J InfectDis. 2005;191(11):1932-1939. (Pubitemid 40705402)
44. Osier FHA, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun. 2008;76(5):2240-2248. (Pubitemid 351656161)
45. Polley SD, et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine. 2004;23(5):718-728. (Pubitemid 39473204)
46. Ataíde R, et al. Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria. PLoS ONE. 2010;5(5):e10807.
47. Jensen ATR, et al. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J Exp Med. 2004;199(9):1179-1190. (Pubitemid 38620255)
48. Bull PC, Lowe BS, Kortok M, Marsh K. Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect Immun. 1999;67(2):733-739. (Pubitemid 29059212)
49. Aguiar J, Albrecht G, Cegielski P. Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. Am J Trop Med Hyg. 1992;47(5):621-632.
50. Baruch DI, Gormely JA, Ma C, Howard RJ, Pasloske BL. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1996;93(8):3497-3502. (Pubitemid 26125649)
51. Rottmann M, et al. Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children. Infect Immun. 2006;74(7):3904-3911. (Pubitemid 43993322)
52. Drakeley CJ, et al. Estimating medium- and longterm trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A. 2005;102(14):5108-5113.
53. Cook J, et al. Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J. 2010;9:169.
54. Persson KEM, Lee CT, Marsh K, Beeson JG. Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies. J Clin Microbiol. 2006;44(5):1665-1673. (Pubitemid 43726253)
55. Hommel M, et al. Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women. Infect Immun. 2010;78(5):1963-1978.
56. Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65(3):418-420. (Pubitemid 10222999)
57. Waterkeyn JG, Cowman AF, Cooke BM. Plasmodium falciparum: gelatin enrichment selects for parasites with full-length chromosome 2. implications for cytoadhesion assays. Exp Parasitol. 2001;97(2):115-118. (Pubitemid 32980608)
58. Beeson JG, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. J Infect Dis. 2004;189(3):540-551. (Pubitemid 38210591)
59. Voss TS, et al. Alterations in local chromatin environment are involved in silencing and activation of subtelomeric var genes in Plasmodium falciparum. Mol Microbiol. 2007;66(1):139-150. (Pubitemid 47414792)
60. Kinyanjui SM, et al. The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes. J Immunol Methods. 2004;288(1-2):9-18. (Pubitemid 38739248)
61. Reeder JC, et al. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. Proc Natl Acad Sci U S A. 1999;96(9):5198-5202. (Pubitemid 29214560)
62. Beeson JG, et al. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variantspecific and cross-reactive antibodies. J Infect Dis. 2006;193(5):721-730. (Pubitemid 43271506)
63. Petter M, et al. Variant proteins of the Plasmodium falciparum RIFIN family show distinct subcellular localization and developmental expression patterns. Mol Biochem Parasitol. 2007;156(1):51-61. (Pubitemid 47348143)
64. Duffy MF, et al. Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype. Mol Microbiol. 2005;56(3):774-788. (Pubitemid 40562369)
65. Petter M, Bonow I, Klinkert MQ. Diverse expression patterns of subgroups of the rif multigene family during Plasmodium falciparum gametocytogenesis. PLoS One. 2008;3(11):e3779.
66. Beeson JG, Rogerson SJ, Brown GV. Evaluating specific adhesion of Plasmodium falciparum-infected erythrocytes to immobilised hyaluronic acid with comparison to binding of mammalian cells. Int J Parasitol. 2002;32(10):1245- 1252. (Pubitemid 35232176)